Bio Break: Tooth-In-Eye Surgery
In this episode of Bio Break, Nick Allan and Joris van der Heijden dive into one of the most astonishing medical innovations we’ve ever come across: osteo-odonto-keratoprosthesis. Or, as Nick quickly dubs it, “tooth in eye surgery.”
This fascinating procedure sounds like science fiction but has been successfully used to restore vision in people who are blind due to damage in the front part of the eye, such as from trauma or autoimmune diseases. While the retina remains functional, traditional options are off the table. That’s where this extreme innovation comes in.
Joris explains how the procedure starts with removing a patient’s tooth and some surrounding bone to create a small square-shaped structure. A hole is drilled in the center, and a tiny lens is implanted, this piece will eventually act as an artificial cornea. But before it’s implanted into the eye, it needs to be biologically prepared. That’s done by temporarily placing the implant into the patient’s cheek, where it can become vascularized over a few months.
Once ready, the patient returns to the hospital for the second stage. Surgeons retrieve the now-living implant from the cheek and carefully insert it into the eye, replacing the damaged corneal area. Thanks to the previously grafted oral tissue, the eye is prepped to accept the implant, and the result is stunning: restored vision in up to 90% of patients.
Even more impressive? Around 50% of these individuals gain high-quality vision, enough to read or even consider driving.
Whether you’re a medtech enthusiast or just love mind-blowing medical stories, this episode is a must-watch. Learn how combining dental tissue, ocular surgery, and a bit of clever biology can give people their sight back.
Five Eye Diseases linked to majority of blindness or poor vision.
Related Resources
In this Bio Break episode, Nick and Nigel explore why some GLP-1 drugs are taken daily while others last a full week, and what drives that difference at a molecular level.
Choosing the right project estimation approach can make or break a medical device program. Learn when to use a gut feel, rough order of magnitude, or detailed estimate to balance speed, accuracy, and risk.
Ozempic is a synthetic version of a hormone your body already makes. That hormone is called GLP-1 (glucagon-like peptide-1), and your intestine releases it naturally when food arrives.
Accelerated aging in medical devices is a testing method used to estimate how a product will perform over time by exposing it to elevated conditions, most often heat. In simple terms, it is a way to simulate months or years of aging in a much shorter timeframe.